Convatec Group PLC (CTEC)
Convatec Group PLC: Director/ PDMR Shareholding

20-Dec-2022 / 17:07 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

20 December 2022

Convatec Group Plc
("Convatec" or "the Company")
Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 19 December 2022, Jonny Mason, Chief Financial Officer and PDMR, purchased 28,000 Shares at £2.27 per Share. Jonny Mason’s resulting shareholding is 50,000 Shares.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/Status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Convatec Group Plc (“Shares”)

GB00BD3VFW73

b)

Nature of the transaction

Purchase of shares on 19 December 2022

c)

Price(s) and volume(s)

Price(s)

£2.27

Volume(s)

28,000

d)

Aggregated information

- Aggregated volume 

- Price

 

28,000

£63,624.62

e)

Date of the transaction

2022-12-19

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

Enquiries 

 

Analysts and Investors 

Kate Postans, VP Investor Relations, Convatec                                                            +44 (0)782 644 7807 

ir@convatec.com 

 

Media 

Buchanan: Charles Ryland / Chris Lane                                                                    +44 (0)207 466 5000  

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

 

About Convatec 
 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, and a promise to be forever caring, our products and services are available in over 100 countries. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. The company is a constituent of the FTSE 100 Index (LSE:CTEC) and in 2021 revenues were over $2 billion. To learn more about Convatec, please visit http://www.convatecgroup.com

 
ISIN: GB00BD3VFW73
Category Code: RDN
TIDM: CTEC
LEI Code: 213800LS272L4FIDOH92
Sequence No.: 210111
EQS News ID: 1518181

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1518181&application_name=news&site_id=webfg

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.